Tricida Inc
Change company Symbol lookup
Select an option...
TCDAQ Tricida Inc
DDOG Datadog Inc
CLX Clorox Co
ATTO Atento SA
TOWN TowneBank
CHWY Chewy Inc
O Realty Income Corp
HOOK HOOKIPA Pharma Inc
AI C3.ai Inc
QSG QuantaSing Group Ltd
Go

Health Care : Pharmaceuticals | Small Cap Value
Company profile

Tricida, Inc. is a pharmaceutical company. The Company is focused on its investigational drug candidate, veverimer (TRC101). TRC101 is a non-absorbed, orally administered polymer designed to treat metabolic acidosis and slow CKD progression by binding and removing acid from the gastrointestinal (GI) tract. Its veverimer, is a low-swelling, spherical polymer bead that is approximately 100 micrometers in diameter, which is a single, molecular weight, crosslinked polyamine molecule. Veverimer is a single, high molecular weight, crosslinked polyamine molecule. The size of veverimer prevents systemic absorption from the GI tract. The high degree of cross-linking within veverimer limits swelling and the overall volume in the GI tract, with the goal of facilitating GI tolerability. It is conducting renal outcomes clinical trial, VALOR-CKD (TRCA-303), to determine if veverimer slows CKD progression in patients with metabolic acidosis associated with CKD.

Closing Price
$0.0117
Day's Change
0.0018 (18.18%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.0119
Day's Low
0.0099
Volume
(Light)
Volume:
18,116

10-day average volume:
247,032
18,116
  • Prev Close
    0.0099
  • Today's Open
    0.0109
  • Day's Range
    0.0099-0.0119
  • Avg Vol (10-day)
    247.0K
  • Last (time)
    3:52p ET 06/01/23
  • Last (size)
    100
  • 52-Wk Range
    0.005 - 13.85
    LowHigh
  • (08/24/22 - 03/29/23)
    134.00%
  • 334.0%
  • Market Cap
    678.9K
  • Shares Outstanding
    58.0M
  • -2.37
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.1
  • 6.28
  • --

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.